KENKO Imalytics is a spin-off from the UPV, founded with the aim of designing and developing a web platform, which includes integrated software (IA Plus Software: latent structural models) that allows the automatic analysis of medical and MRI (Magnetic Resonance Imaging) images with various technologies (perfusion, diffusion, DTI), the calculation of various biomarkers (new and existing on the market) and the integration of these for the generation of a virtual biopsy, in order to detect different types of cancer in early stages. Furthermore, once this software is developed, KENKO sets its goal further to analyze segmented regions of interest (ROIs), that is, the lesions will be segmented and more precise characteristics of the ROIs will be predicted, such as the type of lesion, tumor aggressiveness, capacity or response to treatment, among others.